These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21676438)

  • 1. Risk of in-stent thrombus formation at one year after drug-eluting stent implantation.
    Higo T; Ueda Y; Matsuo K; Nishio M; Hirata A; Asai M; Nemoto T; Murakami A; Kashiwase K; Kodama K
    Thromb Res; 2011 Nov; 128(5):431-4. PubMed ID: 21676438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study.
    Higo T; Ueda Y; Oyabu J; Okada K; Nishio M; Hirata A; Kashiwase K; Ogasawara N; Hirotani S; Kodama K
    JACC Cardiovasc Imaging; 2009 May; 2(5):616-24. PubMed ID: 19442950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of a newly developed yellow neointima at stent implanted site 1 year after sirolimus-eluting stent placement: angioscopic findings.
    Kawakami H; Matsuoka H; Oshita A; Kono T; Shigemi S
    J Cardiol; 2009 Aug; 54(1):153-7. PubMed ID: 19632537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.
    Yamamoto M; Okamatsu K; Inami S; Takano M; Yokoyama S; Ohba T; Ibuki C; Hata N; Seino Y; Mizuno K
    Am Heart J; 2009 Jul; 158(1):99-104. PubMed ID: 19540398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent.
    Oyabu J; Ueda Y; Ogasawara N; Okada K; Hirayama A; Kodama K
    Am Heart J; 2006 Dec; 152(6):1168-74. PubMed ID: 17161071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of angioscopic findings among second-generation drug-eluting stents.
    Nishimoto Y; Ueda Y; Sugihara R; Murakami A; Ueno K; Takeda Y; Hirata A; Kashiwase K; Higuchi Y; Yasumura Y
    J Cardiol; 2017 Sep; 70(3):297-302. PubMed ID: 28034576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary thrombus formation after drug-eluting stents implantation: optical coherence tomographic study.
    Kim JS; Hong MK; Fan C; Kim TH; Shim JM; Park SM; Ko YG; Choi D; Jang Y
    Am Heart J; 2010 Feb; 159(2):278-83. PubMed ID: 20152227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possibility of delayed arterial healing 5 years after implantation of sirolimus-eluting stents: serial observations by coronary angioscopy.
    Yamamoto M; Takano M; Murakami D; Inami T; Kobayashi N; Inami S; Okamatsu K; Ohba T; Ibuki C; Hata N; Seino Y; Jang IK; Mizuno K
    Am Heart J; 2011 Jun; 161(6):1200-6. PubMed ID: 21641369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Chronic Angioscopic Findings of Bare Metal Stents, 1st-Generation Drug-Eluting Stents and 2nd-Generation Drug-Eluting Stents　- Multicenter Study of Intra-Coronary Angioscopy After Stent (MICASA).
    Dai K; Matsuoka H; Kawakami H; Sato T; Watanabe K; Nakama Y; Ishihara M
    Circ J; 2016 Aug; 80(9):1916-21. PubMed ID: 27357218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes after unrestricted use of everolimus-eluting stent compared to paclitaxel- and sirolimus-eluting stents.
    Mahmoudi M; Delhaye C; Wakabayashi K; Ben-Dor I; Gonzalez MA; Maluenda G; Gaglia MA; Torguson R; Xue Z; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2011 Jun; 107(12):1757-62. PubMed ID: 21497782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry).
    Kaltoft A; Jensen LO; Maeng M; Tilsted HH; Thayssen P; Bøttcher M; Lassen JF; Krusell LR; Rasmussen K; Hansen KN; Pedersen L; Johnsen SP; Sørensen HT; Thuesen L
    J Am Coll Cardiol; 2009 Feb; 53(8):658-64. PubMed ID: 19232897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulnerable disease may induce neointimal coverage after sirolimus-eluting stent implantation.
    Nishino M; Hoshida S; Taniike M; Kato H; Egami Y; Shutta R; Yamaguchi H; Tanaka K; Tanouchi J; Yamada Y
    Am Heart J; 2010 Sep; 160(3):564-9. PubMed ID: 20826267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
    Kotani J; Awata M; Nanto S; Uematsu M; Oshima F; Minamiguchi H; Mintz GS; Nagata S
    J Am Coll Cardiol; 2006 May; 47(10):2108-11. PubMed ID: 16697331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry.
    Jensen LO; Tilsted HH; Thayssen P; Kaltoft A; Maeng M; Lassen JF; Hansen KN; Madsen M; Ravkilde J; Johnsen SP; Sørensen HT; Thuesen L
    EuroIntervention; 2010 Apr; 5(8):898-905. PubMed ID: 20542774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular response to paclitaxel-eluting nitinol self-expanding stent in superficial femoral artery lesions: post-implantation angioscopic findings from the SHIMEJI trial (Suppression of vascular wall Healing after IMplantation of drug Eluting peripheral stent in Japanese patients with the Infra inguinal lesion: serial angioscopic observation).
    Tsukiyama Y; Shinke T; Ishihara T; Otake H; Terashita D; Kozuki A; Fukunaga M; Zen K; Horimatsu T; Fujii K; Shite J; Uematsu M; Takahara M; Iida O; Nanto S; Hirata KI
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1777-1784. PubMed ID: 31201589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of angioscopic findings and three-year cardiac events between sirolimus-eluting stent and bare-metal stent in acute myocardial infarction.
    Nishino M; Yoshimura T; Nakamura D; Lee Y; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    Am J Cardiol; 2011 Nov; 108(9):1238-43. PubMed ID: 21840490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.
    Kimura T; Morimoto T; Nakagawa Y; Kawai K; Miyazaki S; Muramatsu T; Shiode N; Namura M; Sone T; Oshima S; Nishikawa H; Hiasa Y; Hayashi Y; Nobuyoshi M; Mitudo K;
    Circulation; 2012 Jan; 125(4):584-91. PubMed ID: 22203694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of long-term clinical outcome after successful implantation of Firebird sirolimus- and Taxus paclitaxel-eluting stents in Chinese population: analysis of a large single center registry.
    Dou KF; Xu B; Yang YJ; Chen JL; Qiao SB; Wang Y; Li JJ; Qin XW; Yao M; Liu HB; Wu YJ; Chen J; Yuan JQ; You SJ; Li W; Gao RL
    Chin Med J (Engl); 2010 Apr; 123(7):810-5. PubMed ID: 20497669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P
    J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angioscopic Comparison of Resolute and Endeavor Zotarolimus-Eluting Stents.
    Nishimoto Y; Matsuo K; Ueda Y; Sugihara R; Hirata A; Murakami A; Kashiwase K; Higuchi Y; Yasumura Y
    Circ J; 2016; 80(3):650-6. PubMed ID: 26794153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.